Published in C R Acad Sci Hebd Seances Acad Sci D on August 16, 1972
Importance of the vasoactive intestinal peptide receptor in the stimulation of cyclic adenosine 3',5'-monophosphate in gallbladder epithelial cells of man. Comparison with the guinea pig. J Clin Invest (1981) 0.86
Rapid glucocorticoid inhibition of vasoactive intestinal peptide-induced cyclic AMP accumulation and prolactin release in rat pituitary cells in culture. Proc Natl Acad Sci U S A (1981) 0.79
Separation of antibody-bound and unbound peptide hormones labelled with iodine-131 by talcum powder and precipitated silica. Nature (1966) 3.17
Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia (1980) 1.74
Impairment of insulin binding to the fat cell plasma membrane in the obese hyperglycemic mouse. FEBS Lett (1972) 1.71
Diabetogenic effect of streptozotocin in the rat during the perinatal period. Diabetes (1974) 1.27
Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in culture. Proc Natl Acad Sci U S A (1978) 1.21
[The effects of perfusion and amino acid ingestion in glucagonenemia]. Journ Annu Diabetol Hotel Dieu (1967) 1.11
Porcine peptide having N-terminal histidine and C-terminal isoleucine amide (PHI): vasoactive intestinal peptide (VIP) and secretin-like effects in different tissues from the rat. FEBS Lett (1980) 1.11
The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. J Hypertens (1996) 1.05
Interactions of glucagon, gut glucagon, vasoactive intestinal polypeptide and secretin with liver and fat cell plasma membranes: binding to specific sites and stimulation of adenylate cyclase. Endocrinology (1974) 1.03
Chicken insulin: radioimmunological characterization and enhanced activity in rat fat cells and liver plasma membranes. Endocrinology (1974) 1.01
Demonstration of specific receptors for EGF--urogastrone in isolated rat intestinal epithelial cells. FEBS Lett (1980) 1.01
High plasma nonesterified fatty acids are predictive of cancer mortality but not of coronary heart disease mortality: results from the Paris Prospective Study. Am J Epidemiol (2001) 0.99
Cyclic AMP production in isolated colonic epithelial crypts: a highly sensitive model for the evaluation of vasoactive intestinal peptide action in human intestine. Eur J Clin Invest (1980) 0.99
Expression of glucagon-like peptide 1 receptor in a murine C cell line: regulation of calcitonin gene by glucagon-like peptide 1. FEBS Lett (1996) 0.98
Evidence for the presence of insulin binding sites in isolated rat intestinal epithelial cells. Diabetologia (1980) 0.97
Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes. Diabetologia (1979) 0.95
Glucagon antibodies. Lancet (1965) 0.95
Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1. Life Sci (1983) 0.92
Interaction of vasoactive intestinal peptide with isolated intestinal epithelial cells from rat. 1. Characterization, quantitative aspects and structural requirements of binding sites. Eur J Biochem (1979) 0.92
Vasoactive intestinal peptide (VIP): variation of the jejuno-ileal content in the developing rat as measured by radioreceptorassay. Acta Endocrinol (Copenh) (1977) 0.91
Transfection of fetal rat intestinal epithelial cells by viral oncogenes: establishment and characterization of the E1A-immortalized SLC-11 cell line. Proc Natl Acad Sci U S A (1989) 0.91
Vasoactive intestinal peptide (VIP): brain distribution, subcellular localization and effect of deafferentation of the hypothalamus in male rats. Brain Res (1979) 0.90
Vasoactive intestinal peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL release. FEBS Lett (1979) 0.90
Vasoactive intestinal peptide (VIP) control of glycogenolysis in the human colon carcinoma cell line HT-29 in culture. FEBS Lett (1981) 0.89
Differential transferrin receptor density in human colorectal cancer: A potential probe for diagnosis and therapy. Int J Oncol (1998) 0.89
[Intestinal vasoactive peptide receptors in enterocytes : specific binding and stimulation of cyclic AMP]. C R Acad Sci Hebd Seances Acad Sci D (1977) 0.89
The interaction of glucagon, gastric inhibitory peptide and somatostatin with cyclic AMP production systems present in rat gastric glands. Biochim Biophys Acta (1982) 0.88
Growth hormone as a risk for premature mortality in healthy subjects: data from the Paris prospective study. BMJ (1998) 0.87
Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality. The Paris Prospective Study. Arterioscler Thromb (1992) 0.87
Vasoactive intestinal peptide control of cyclic adenosine 3':5'-monophosphate levels in seven human colorectal adenocarcinoma cell lines in culture. Cancer Res (1980) 0.86
Beta-adrenergic regulation of cyclic adenosine 3',5' monophosphate accumulation in human gastric epithelial glands. Inhibitory effect of somatostatin. Eur J Clin Invest (1984) 0.86
Characterization of specific binding sites for vasoactive intestinal peptide in rat intestinal epithelial cell membranes. Biochim Biophys Acta (1980) 0.86
"Enterolglucagon': a specific effect on gastric glands isolated from the rat fundus. Evidence for an "oxyntomodulin' action. Biosci Rep (1981) 0.86
Importance of the vasoactive intestinal peptide receptor in the stimulation of cyclic adenosine 3',5'-monophosphate in gallbladder epithelial cells of man. Comparison with the guinea pig. J Clin Invest (1981) 0.86
Experimental chemical diabetes and pregnancy in the rat. Evolution of glucose tolerance and insulin response. Diabetes (1982) 0.86
Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide. FEBS Lett (1982) 0.86
Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Isolation of the peptide. FEBS Lett (1982) 0.85
A new neuroregulator: the vasoactive intestinal peptide or VIP. Mol Cell Endocrinol (1982) 0.85
Regulation by vasoactive intestinal peptide, histamine, somatostatin-14 and -28 of cyclic adenosine monophosphate levels in gastric glands isolated from the guinea pig fundus or antrum. Endocrinology (1983) 0.85
Hormonal control of phenylalanine hydroxylase activity in isolated rat hepatocytes. Biochem Biophys Res Commun (1980) 0.85
Body mass, blood pressure, glucose, and lipids. Does plasma insulin explain their relationships? Arteriosclerosis (1987) 0.84
Postmaturity in the rat: impairment of insulin, glucagon, and glycogen stores. Diabetologia (1976) 0.84
The receptors of the VIP family peptides (VIP, secretin, GRF, PHI, PHM, GIP, glucagon and oxyntomodulin). Specificities and identity. Peptides (1986) 0.84
Characterization and repartition of epidermal growth factor-urogastrone receptors in gastric glands isolated from young and adult guinea pigs. Biochim Biophys Acta (1984) 0.84
Nutritionally induced variations in insulinaemia, blood ketone bodies and plasma and liver triglycerides in genetically obese rats. Diabete Metab (1977) 0.83
Bioactive enteroglucagon (oxyntomodulin): present knowledge on its chemical structure and its biological activities. Peptides (1981) 0.83
Characterization of a vasoactive intestinal peptide-sensitive adenylate cyclase in rat intestinal epithelial cell membranes. Biochim Biophys Acta (1978) 0.83
Vasoactive intestinal peptide receptor activity and specificity during enterocyte-like differentiation and retrodifferentiation of the human colonic cancerous subclone HT29-18. FEBS Lett (1985) 0.83
The interaction of secretin with pancreatic membranes. Biochim Biophys Acta (1976) 0.83
Metabolism of genetically obese rates on normal or high-fat diet. Diabetologia (1974) 0.82
[Study of 8 cases of primary hemochromatosis, including in particular the plasma radio-immunologic determination of somatotropic and follicle-stimulating hormones and glucagon]. Pathol Biol (1968) 0.82
Characterization and autoradiographic distribution of vasoactive intestinal peptide binding sites in the rat central nervous system. Brain Res (1986) 0.82
Secretin receptor activity in rat gastric glands. Binding studies, cAMP generation and pharmacology. Peptides (1986) 0.81
Characterization of vasoactive intestinal peptide receptors in human colonic epithelial cells. J Clin Endocrinol Metab (1981) 0.81
Growth hormone and insulin binding to isolated hepatocytes in the genetically dwarf mouse. Biochim Biophys Acta (1980) 0.81
[Receptors for vasoactic intestinal peptide (VIP) in human colonic adenocarcinoma membranes: specific binding and stimulation of adenylate cyclase]. C R Acad Sci Hebd Seances Acad Sci D (1978) 0.81
Effect of feeding and fasting on the early steps of glucagon action in isolated rat liver cells. Endocrinology (1976) 0.81
Vasoactive intestinal peptide receptor regulation and reversible desensitization in human colonic carcinoma cells in culture. Cancer Res (1986) 0.81
Effect of vasoactive intestinal peptide (VIP) on the release of adenohypophyseal hormones from purified cells obtained by unit gravity sedimentation. Inhibition by dexamethasone of vip-induced prolactin release. Neuroendocrinology (1980) 0.81
Metabolic clearance of insulin from the cerebrospinal fluid in the anesthetized rat. Peptides (1990) 0.81
Interaction of amino acids and cyclic AMP on the release of insulin and glucagon by newborn rat pancreas. Endocrinology (1975) 0.81
Dynamics of pancreatic cell growth and differentiation during diabetes reversion in STZ-treated newborn rats. Am J Physiol (1995) 0.81
Regulation by vasoactive intestinal peptide of cyclic AMP accumulation in gastric epithelial glands. A characteristic of human stomach. FEBS Lett (1980) 0.81
Selective inhibition by somatostatin of cyclic AMP production in rat gastric glands: demonstration of a direct effect on the parietal cell function. FEBS Lett (1980) 0.80
Portal insulin and glucagon in rats fed proteins as a meal: immediate variations and circadian modulations. J Nutr (1980) 0.80
Histamine interaction on surface recognition sites of H2-type in parietal and non-parietal cells isolated from the guinea pig stomach. FEBS Lett (1982) 0.80
Ontogenic development of vasoactive intestinal peptide receptors in rat intestinal cells and liver. Endocrinology (1987) 0.80
Vasoactive intestinal peptide (VIP): tissue distribution in the rat as measured by radioimmunoassay and by radioreceptorassay. Acta Endocrinol (Copenh) (1978) 0.80
Cell-specific localization of G protein alpha-subunits in the islets of Langerhans. J Endocrinol (1999) 0.80
Development of the beta cells. Mt Sinai J Med (1992) 0.80
Pharmacology and molecular identification of secretin receptors in rat gastric glands. Life Sci (1988) 0.80
Biosynthesis of proinsulin and insulin in newborn rat pancreas. Interaction of glucose, cyclic AMP, somatostatin, and sulfonylureas on the (3H) leucine incorporation into immunoreactive insulin. J Clin Invest (1976) 0.80
Effects of hyperinsulinemia on local cerebral insulin binding and glucose utilization in normoglycemic awake rats. Neurosci Lett (1990) 0.79
Gastric inhibitory peptide (GIP), pancreatic glucagon and vasoactive intestinal peptide (VIP) are cAMP-inducing hormones in the human gastric cancer cell line HGT-1. Homologous desensitization of VIP receptor activity. Biochem Biophys Res Commun (1984) 0.79
Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas. Am J Physiol (1991) 0.79
Rapid inhibition by somatostatin of vasoactive intestinal peptide-induced prolactin secretion by rat pituitary cells. Relationship to cyclic AMP accumulation. FEBS Lett (1982) 0.79
Tissue distribution of 131I radiolabeled transferrin in the athymic nude mouse: localization of a human colon adenocarcinoma HT-29 xenograft. Int J Rad Appl Instrum B (1990) 0.79
Transfer of the hormone receptor for vaso-intestinal peptide to an adenylate cyclase system in another cell. FEBS Lett (1979) 0.79
Secretin binding sites coupled with adenylate cyclase in rat fundic membranes. Peptides (1981) 0.79
Rapid glucocorticoid inhibition of vasoactive intestinal peptide-induced cyclic AMP accumulation and prolactin release in rat pituitary cells in culture. Proc Natl Acad Sci U S A (1981) 0.79
Structural requirements for glucagon receptor binding and activation of adenylate cyclase in liver. Study of chemically modified forms of the hormone, including N alpha-trinitrophenyl glucagon, an antagonist. J Biol Chem (1981) 0.79
Stimulatory transducing systems in pancreatic islet cells. Ann N Y Acad Sci (1998) 0.79
[Cyclic AMP, mediator of glucagon secretion due to amino acids]. C R Acad Sci Hebd Seances Acad Sci D (1973) 0.79
Evidence for a cyclic AMP system highly sensitive to secretin in gastric glands isolated from the rat fundus and antrum. Biochim Biophys Acta (1980) 0.78
[Secretion of insulin and glucagon by the pancreas in newborn rats: effect of glucose and 3'-5'cyclic AMP adensine monophosphate]. C R Acad Sci Hebd Seances Acad Sci D (1973) 0.78
In vitro biochemical characterization and autoradiographic distribution of 3H-thyrotropin-releasing hormone binding sites in rat brain sections. Neuroendocrinology (1984) 0.78
Ultrastructural evidence for endogenous vasoactive intestinal peptide-like immunoreactivity in the pituitary gland. Neuroendocrinology (1982) 0.78
Functional receptors for VIP, GIP, glucagon-29 and -37 in the HGT-1 human gastric cancer cell line. Peptides (1986) 0.78
Enhanced binding affinity of chicken insulin in rat liver membranes and human lymphocytes: relationship tothe kinetic properties of the hormone- receptor interaction. Endocrinology (1977) 0.78
Glucose intolerance in uraemia. II. Plasma growth hormone and glucagon values. Diabetologia (1969) 0.78
Quantitative studies of vasoactive intestinal peptide (VIP) binding sites and VIP-induced adenosine 3':5'-monophosphate production in epithelial cells from duodenum, jejunum, ileum, cecum, colon and rectum in the rat. Acta Endocrinol (Copenh) (1981) 0.78
Insulin and glucagon-receptor interactions in the genetically obese Zucker rat: studies of hormone binding and glucagon-stimulated cyclic AMP levels in isolated hepatocytes. Endocrinology (1977) 0.78
[Calmodulin regulation of intestinal epithelium adenylate cyclase (author's transl)]. C R Seances Acad Sci III (1982) 0.77
Ontogeny of gastric inhibitory peptide in the human gastro-intestinal tract and endocrine pancreas. Acta Endocrinol (Copenh) (1982) 0.77